nodes	percent_of_prediction	percent_of_DWPC	metapath
Aripiprazole—CYP3A7—Vincristine—sarcoma	0.0435	0.116	CbGbCtD
Aripiprazole—CYP3A7-CYP3A51P—Vincristine—sarcoma	0.0435	0.116	CbGbCtD
Aripiprazole—CYP3A4—Thiotepa—sarcoma	0.0431	0.115	CbGbCtD
Aripiprazole—ABCB1—Dactinomycin—sarcoma	0.0345	0.0919	CbGbCtD
Aripiprazole—CYP3A5—Vincristine—sarcoma	0.0327	0.087	CbGbCtD
Aripiprazole—ABCB1—Mitoxantrone—sarcoma	0.0309	0.0822	CbGbCtD
Aripiprazole—CYP3A5—Etoposide—sarcoma	0.0299	0.0797	CbGbCtD
Aripiprazole—ABCB1—Vincristine—sarcoma	0.0213	0.0566	CbGbCtD
Aripiprazole—ABCB1—Etoposide—sarcoma	0.0195	0.0519	CbGbCtD
Aripiprazole—HTR1D—meninx—sarcoma	0.0186	0.119	CbGeAlD
Aripiprazole—CYP3A4—Mitoxantrone—sarcoma	0.0185	0.0493	CbGbCtD
Aripiprazole—HTR1B—dura mater—sarcoma	0.0177	0.113	CbGeAlD
Aripiprazole—HTR1D—dura mater—sarcoma	0.0171	0.11	CbGeAlD
Aripiprazole—ABCB1—Doxorubicin—sarcoma	0.0133	0.0354	CbGbCtD
Aripiprazole—CYP3A4—Vincristine—sarcoma	0.0127	0.0339	CbGbCtD
Aripiprazole—CYP2D6—Doxorubicin—sarcoma	0.0125	0.0333	CbGbCtD
Aripiprazole—CYP3A4—Etoposide—sarcoma	0.0117	0.0311	CbGbCtD
Aripiprazole—CYP3A4—Doxorubicin—sarcoma	0.00796	0.0212	CbGbCtD
Aripiprazole—CHRM3—muscle of abdomen—sarcoma	0.00721	0.0464	CbGeAlD
Aripiprazole—HTR7—pulmonary artery—sarcoma	0.00581	0.0374	CbGeAlD
Aripiprazole—HTR2A—pulmonary artery—sarcoma	0.00362	0.0233	CbGeAlD
Aripiprazole—HTR1E—myometrium—sarcoma	0.00285	0.0183	CbGeAlD
Aripiprazole—H1F0—mammary gland—sarcoma	0.00238	0.0153	CbGeAlD
Aripiprazole—HTR2A—hindlimb—sarcoma	0.00219	0.0141	CbGeAlD
Aripiprazole—HTR2A—appendage—sarcoma	0.00188	0.0121	CbGeAlD
Aripiprazole—DRD5—hematopoietic system—sarcoma	0.00187	0.012	CbGeAlD
Aripiprazole—HTR7—endothelium—sarcoma	0.00182	0.0117	CbGeAlD
Aripiprazole—H1F0—myometrium—sarcoma	0.00169	0.0108	CbGeAlD
Aripiprazole—H1F0—embryo—sarcoma	0.00162	0.0104	CbGeAlD
Aripiprazole—DRD4—testis—sarcoma	0.00156	0.01	CbGeAlD
Aripiprazole—H1F0—seminal vesicle—sarcoma	0.00152	0.0098	CbGeAlD
Aripiprazole—CHRM5—skin of body—sarcoma	0.00146	0.00939	CbGeAlD
Aripiprazole—H1F0—hematopoietic system—sarcoma	0.00145	0.00931	CbGeAlD
Aripiprazole—H1F0—connective tissue—sarcoma	0.00139	0.00897	CbGeAlD
Aripiprazole—HTR3A—hematopoietic system—sarcoma	0.00138	0.00888	CbGeAlD
Aripiprazole—DRD5—lymphoid tissue—sarcoma	0.00132	0.00847	CbGeAlD
Aripiprazole—H1F0—smooth muscle tissue—sarcoma	0.00128	0.0082	CbGeAlD
Aripiprazole—H1F0—skin of body—sarcoma	0.00126	0.0081	CbGeAlD
Aripiprazole—HTR2B—myometrium—sarcoma	0.00122	0.00782	CbGeAlD
Aripiprazole—CHRM4—testis—sarcoma	0.00118	0.00757	CbGeAlD
Aripiprazole—HTR2A—endothelium—sarcoma	0.00113	0.0073	CbGeAlD
Aripiprazole—H1F0—cardiac atrium—sarcoma	0.0011	0.00707	CbGeAlD
Aripiprazole—H1F0—uterus—sarcoma	0.00109	0.00704	CbGeAlD
Aripiprazole—HTR1D—connective tissue—sarcoma	0.00108	0.00695	CbGeAlD
Aripiprazole—SLC6A4—hematopoietic system—sarcoma	0.00105	0.00677	CbGeAlD
Aripiprazole—ADRB1—connective tissue—sarcoma	0.00105	0.00675	CbGeAlD
Aripiprazole—H1F0—lymphoid tissue—sarcoma	0.00102	0.00656	CbGeAlD
Aripiprazole—CYP3A7—liver—sarcoma	0.00101	0.00651	CbGeAlD
Aripiprazole—KCNH2—myometrium—sarcoma	0.00097	0.00624	CbGeAlD
Aripiprazole—H1F0—tendon—sarcoma	0.000959	0.00616	CbGeAlD
Aripiprazole—ADRA2C—myometrium—sarcoma	0.000957	0.00615	CbGeAlD
Aripiprazole—HTR1A—hematopoietic system—sarcoma	0.000935	0.00601	CbGeAlD
Aripiprazole—H1F0—bone marrow—sarcoma	0.000929	0.00597	CbGeAlD
Aripiprazole—HTR2B—smooth muscle tissue—sarcoma	0.000919	0.00591	CbGeAlD
Aripiprazole—HTR2B—skin of body—sarcoma	0.000907	0.00583	CbGeAlD
Aripiprazole—HTR7—hematopoietic system—sarcoma	0.000894	0.00575	CbGeAlD
Aripiprazole—KCNH2—seminal vesicle—sarcoma	0.000876	0.00563	CbGeAlD
Aripiprazole—ADRA2C—seminal vesicle—sarcoma	0.000864	0.00556	CbGeAlD
Aripiprazole—ADRA1A—hematopoietic system—sarcoma	0.000862	0.00554	CbGeAlD
Aripiprazole—CYP3A7-CYP3A51P—liver—sarcoma	0.000861	0.00553	CbGeAlD
Aripiprazole—HTR7—connective tissue—sarcoma	0.000861	0.00553	CbGeAlD
Aripiprazole—KCNH2—hematopoietic system—sarcoma	0.000833	0.00535	CbGeAlD
Aripiprazole—ADRB1—cardiac atrium—sarcoma	0.000828	0.00532	CbGeAlD
Aripiprazole—CHRM3—smooth muscle tissue—sarcoma	0.000827	0.00532	CbGeAlD
Aripiprazole—H1F0—testis—sarcoma	0.000794	0.0051	CbGeAlD
Aripiprazole—HTR2B—uterus—sarcoma	0.000788	0.00507	CbGeAlD
Aripiprazole—HTR7—smooth muscle tissue—sarcoma	0.000787	0.00506	CbGeAlD
Aripiprazole—HRH1—myometrium—sarcoma	0.000777	0.005	CbGeAlD
Aripiprazole—ADRA2A—myometrium—sarcoma	0.000763	0.00491	CbGeAlD
Aripiprazole—H1F0—liver—sarcoma	0.00075	0.00483	CbGeAlD
Aripiprazole—HTR2B—tendon—sarcoma	0.000691	0.00444	CbGeAlD
Aripiprazole—ADRA2A—seminal vesicle—sarcoma	0.00069	0.00443	CbGeAlD
Aripiprazole—CYP3A5—hematopoietic system—sarcoma	0.000688	0.00442	CbGeAlD
Aripiprazole—HRH1—hematopoietic system—sarcoma	0.000667	0.00429	CbGeAlD
Aripiprazole—ADRA2A—hematopoietic system—sarcoma	0.000656	0.00421	CbGeAlD
Aripiprazole—HRH1—connective tissue—sarcoma	0.000643	0.00413	CbGeAlD
Aripiprazole—KCNH2—cardiac atrium—sarcoma	0.000632	0.00407	CbGeAlD
Aripiprazole—ADRA2A—connective tissue—sarcoma	0.000631	0.00406	CbGeAlD
Aripiprazole—KCNH2—uterus—sarcoma	0.000629	0.00404	CbGeAlD
Aripiprazole—HTR2A—embryo—sarcoma	0.000624	0.00401	CbGeAlD
Aripiprazole—ADRA2C—cardiac atrium—sarcoma	0.000624	0.00401	CbGeAlD
Aripiprazole—ADRA2C—uterus—sarcoma	0.000621	0.00399	CbGeAlD
Aripiprazole—ADRA1A—lymphoid tissue—sarcoma	0.000607	0.0039	CbGeAlD
Aripiprazole—HTR7—tendon—sarcoma	0.000592	0.0038	CbGeAlD
Aripiprazole—HRH1—smooth muscle tissue—sarcoma	0.000588	0.00378	CbGeAlD
Aripiprazole—H1F0—lymph node—sarcoma	0.000575	0.0037	CbGeAlD
Aripiprazole—HTR2A—hematopoietic system—sarcoma	0.000557	0.00358	CbGeAlD
Aripiprazole—ADRA2C—tendon—sarcoma	0.000544	0.0035	CbGeAlD
Aripiprazole—HTR2A—connective tissue—sarcoma	0.000537	0.00345	CbGeAlD
Aripiprazole—KCNH2—bone marrow—sarcoma	0.000534	0.00343	CbGeAlD
Aripiprazole—CYP3A4—hematopoietic system—sarcoma	0.000516	0.00332	CbGeAlD
Aripiprazole—CHRM3—testis—sarcoma	0.000515	0.00331	CbGeAlD
Aripiprazole—CYP2D6—hematopoietic system—sarcoma	0.000508	0.00326	CbGeAlD
Aripiprazole—ADRA2A—cardiac atrium—sarcoma	0.000498	0.0032	CbGeAlD
Aripiprazole—ADRA2A—uterus—sarcoma	0.000495	0.00318	CbGeAlD
Aripiprazole—HTR2A—smooth muscle tissue—sarcoma	0.000491	0.00316	CbGeAlD
Aripiprazole—HTR7—testis—sarcoma	0.00049	0.00315	CbGeAlD
Aripiprazole—DRD2—testis—sarcoma	0.000463	0.00298	CbGeAlD
Aripiprazole—HTR7—liver—sarcoma	0.000463	0.00298	CbGeAlD
Aripiprazole—KCNH2—testis—sarcoma	0.000456	0.00293	CbGeAlD
Aripiprazole—ADRA2C—testis—sarcoma	0.00045	0.00289	CbGeAlD
Aripiprazole—ADRA1A—liver—sarcoma	0.000447	0.00287	CbGeAlD
Aripiprazole—HRH1—tendon—sarcoma	0.000442	0.00284	CbGeAlD
Aripiprazole—ADRA2A—tendon—sarcoma	0.000434	0.00279	CbGeAlD
Aripiprazole—ADRA2C—liver—sarcoma	0.000426	0.00274	CbGeAlD
Aripiprazole—ABCB1—myometrium—sarcoma	0.000425	0.00274	CbGeAlD
Aripiprazole—HTR2B—lymph node—sarcoma	0.000415	0.00267	CbGeAlD
Aripiprazole—ABCB1—embryo—sarcoma	0.000409	0.00263	CbGeAlD
Aripiprazole—ABCB1—seminal vesicle—sarcoma	0.000384	0.00247	CbGeAlD
Aripiprazole—HTR2A—tendon—sarcoma	0.000369	0.00237	CbGeAlD
Aripiprazole—HRH1—testis—sarcoma	0.000366	0.00235	CbGeAlD
Aripiprazole—ABCB1—hematopoietic system—sarcoma	0.000365	0.00235	CbGeAlD
Aripiprazole—ADRA2A—testis—sarcoma	0.000359	0.00231	CbGeAlD
Aripiprazole—CYP3A5—liver—sarcoma	0.000356	0.00229	CbGeAlD
Aripiprazole—KCNH2—lymph node—sarcoma	0.000331	0.00213	CbGeAlD
Aripiprazole—ADRA2C—lymph node—sarcoma	0.000326	0.0021	CbGeAlD
Aripiprazole—HTR2A—testis—sarcoma	0.000305	0.00196	CbGeAlD
Aripiprazole—HTR2A—liver—sarcoma	0.000289	0.00186	CbGeAlD
Aripiprazole—CYP2D6—testis—sarcoma	0.000278	0.00179	CbGeAlD
Aripiprazole—ABCB1—uterus—sarcoma	0.000276	0.00177	CbGeAlD
Aripiprazole—CYP3A4—liver—sarcoma	0.000267	0.00172	CbGeAlD
Aripiprazole—HRH1—lymph node—sarcoma	0.000265	0.0017	CbGeAlD
Aripiprazole—CYP2D6—liver—sarcoma	0.000263	0.00169	CbGeAlD
Aripiprazole—ADRA2A—lymph node—sarcoma	0.00026	0.00167	CbGeAlD
Aripiprazole—ABCB1—lymphoid tissue—sarcoma	0.000257	0.00165	CbGeAlD
Aripiprazole—ABCB1—bone marrow—sarcoma	0.000234	0.00151	CbGeAlD
Aripiprazole—ABCB1—testis—sarcoma	0.0002	0.00129	CbGeAlD
Aripiprazole—ABCB1—liver—sarcoma	0.000189	0.00122	CbGeAlD
Aripiprazole—Dermatitis—Thiotepa—sarcoma	0.000181	0.000419	CcSEcCtD
Aripiprazole—Headache—Thiotepa—sarcoma	0.00018	0.000417	CcSEcCtD
Aripiprazole—Rash—Dactinomycin—sarcoma	0.000179	0.000416	CcSEcCtD
Aripiprazole—Decreased appetite—Etoposide—sarcoma	0.000179	0.000415	CcSEcCtD
Aripiprazole—Renal failure—Epirubicin—sarcoma	0.000178	0.000413	CcSEcCtD
Aripiprazole—Gastrointestinal disorder—Etoposide—sarcoma	0.000178	0.000412	CcSEcCtD
Aripiprazole—Asthenia—Mitoxantrone—sarcoma	0.000178	0.000412	CcSEcCtD
Aripiprazole—Fatigue—Etoposide—sarcoma	0.000178	0.000412	CcSEcCtD
Aripiprazole—Neuropathy peripheral—Epirubicin—sarcoma	0.000177	0.000411	CcSEcCtD
Aripiprazole—Jaundice—Epirubicin—sarcoma	0.000176	0.000409	CcSEcCtD
Aripiprazole—Stomatitis—Epirubicin—sarcoma	0.000176	0.000409	CcSEcCtD
Aripiprazole—Pain—Etoposide—sarcoma	0.000176	0.000408	CcSEcCtD
Aripiprazole—Constipation—Etoposide—sarcoma	0.000176	0.000408	CcSEcCtD
Aripiprazole—Conjunctivitis—Epirubicin—sarcoma	0.000176	0.000408	CcSEcCtD
Aripiprazole—Urinary tract infection—Epirubicin—sarcoma	0.000176	0.000408	CcSEcCtD
Aripiprazole—Dysuria—Doxorubicin—sarcoma	0.000176	0.000407	CcSEcCtD
Aripiprazole—Neutropenia—Doxorubicin—sarcoma	0.000176	0.000407	CcSEcCtD
Aripiprazole—Upper respiratory tract infection—Doxorubicin—sarcoma	0.000175	0.000405	CcSEcCtD
Aripiprazole—Diarrhoea—Vincristine—sarcoma	0.000174	0.000403	CcSEcCtD
Aripiprazole—Sweating—Epirubicin—sarcoma	0.000173	0.000402	CcSEcCtD
Aripiprazole—Pollakiuria—Doxorubicin—sarcoma	0.000173	0.000402	CcSEcCtD
Aripiprazole—Haematuria—Epirubicin—sarcoma	0.000173	0.0004	CcSEcCtD
Aripiprazole—Photosensitivity reaction—Doxorubicin—sarcoma	0.000171	0.000398	CcSEcCtD
Aripiprazole—Hepatobiliary disease—Epirubicin—sarcoma	0.000171	0.000397	CcSEcCtD
Aripiprazole—Weight increased—Doxorubicin—sarcoma	0.000171	0.000396	CcSEcCtD
Aripiprazole—Epistaxis—Epirubicin—sarcoma	0.000171	0.000396	CcSEcCtD
Aripiprazole—Nausea—Thiotepa—sarcoma	0.00017	0.000395	CcSEcCtD
Aripiprazole—Weight decreased—Doxorubicin—sarcoma	0.00017	0.000394	CcSEcCtD
Aripiprazole—Sinusitis—Epirubicin—sarcoma	0.00017	0.000394	CcSEcCtD
Aripiprazole—Feeling abnormal—Etoposide—sarcoma	0.00017	0.000394	CcSEcCtD
Aripiprazole—Hyperglycaemia—Doxorubicin—sarcoma	0.000169	0.000393	CcSEcCtD
Aripiprazole—Diarrhoea—Mitoxantrone—sarcoma	0.000169	0.000393	CcSEcCtD
Aripiprazole—Nausea—Dactinomycin—sarcoma	0.000169	0.000392	CcSEcCtD
Aripiprazole—Agranulocytosis—Epirubicin—sarcoma	0.000169	0.000392	CcSEcCtD
Aripiprazole—Pneumonia—Doxorubicin—sarcoma	0.000168	0.000391	CcSEcCtD
Aripiprazole—Gastrointestinal pain—Etoposide—sarcoma	0.000168	0.000391	CcSEcCtD
Aripiprazole—Dizziness—Vincristine—sarcoma	0.000168	0.00039	CcSEcCtD
Aripiprazole—Infestation NOS—Doxorubicin—sarcoma	0.000167	0.000388	CcSEcCtD
Aripiprazole—Infestation—Doxorubicin—sarcoma	0.000167	0.000388	CcSEcCtD
Aripiprazole—Bradycardia—Epirubicin—sarcoma	0.000165	0.000384	CcSEcCtD
Aripiprazole—Renal failure—Doxorubicin—sarcoma	0.000165	0.000382	CcSEcCtD
Aripiprazole—Neuropathy peripheral—Doxorubicin—sarcoma	0.000164	0.000381	CcSEcCtD
Aripiprazole—Urticaria—Etoposide—sarcoma	0.000164	0.000379	CcSEcCtD
Aripiprazole—Haemoglobin—Epirubicin—sarcoma	0.000163	0.000379	CcSEcCtD
Aripiprazole—Stomatitis—Doxorubicin—sarcoma	0.000163	0.000379	CcSEcCtD
Aripiprazole—Jaundice—Doxorubicin—sarcoma	0.000163	0.000379	CcSEcCtD
Aripiprazole—Rhinitis—Epirubicin—sarcoma	0.000163	0.000378	CcSEcCtD
Aripiprazole—Body temperature increased—Etoposide—sarcoma	0.000163	0.000378	CcSEcCtD
Aripiprazole—Abdominal pain—Etoposide—sarcoma	0.000163	0.000378	CcSEcCtD
Aripiprazole—Conjunctivitis—Doxorubicin—sarcoma	0.000163	0.000378	CcSEcCtD
Aripiprazole—Urinary tract infection—Doxorubicin—sarcoma	0.000163	0.000378	CcSEcCtD
Aripiprazole—Haemorrhage—Epirubicin—sarcoma	0.000162	0.000377	CcSEcCtD
Aripiprazole—Hepatitis—Epirubicin—sarcoma	0.000162	0.000377	CcSEcCtD
Aripiprazole—Hypoaesthesia—Epirubicin—sarcoma	0.000162	0.000375	CcSEcCtD
Aripiprazole—Vomiting—Vincristine—sarcoma	0.000162	0.000375	CcSEcCtD
Aripiprazole—Pharyngitis—Epirubicin—sarcoma	0.000161	0.000374	CcSEcCtD
Aripiprazole—Sweating—Doxorubicin—sarcoma	0.000161	0.000372	CcSEcCtD
Aripiprazole—Urinary tract disorder—Epirubicin—sarcoma	0.00016	0.000372	CcSEcCtD
Aripiprazole—Rash—Vincristine—sarcoma	0.00016	0.000372	CcSEcCtD
Aripiprazole—Dermatitis—Vincristine—sarcoma	0.00016	0.000371	CcSEcCtD
Aripiprazole—Oedema peripheral—Epirubicin—sarcoma	0.00016	0.000371	CcSEcCtD
Aripiprazole—Haematuria—Doxorubicin—sarcoma	0.00016	0.00037	CcSEcCtD
Aripiprazole—Connective tissue disorder—Epirubicin—sarcoma	0.00016	0.00037	CcSEcCtD
Aripiprazole—Urethral disorder—Epirubicin—sarcoma	0.000159	0.000369	CcSEcCtD
Aripiprazole—Headache—Vincristine—sarcoma	0.000159	0.000369	CcSEcCtD
Aripiprazole—Hepatobiliary disease—Doxorubicin—sarcoma	0.000158	0.000367	CcSEcCtD
Aripiprazole—Epistaxis—Doxorubicin—sarcoma	0.000158	0.000366	CcSEcCtD
Aripiprazole—Vomiting—Mitoxantrone—sarcoma	0.000157	0.000365	CcSEcCtD
Aripiprazole—Sinusitis—Doxorubicin—sarcoma	0.000157	0.000364	CcSEcCtD
Aripiprazole—Visual impairment—Epirubicin—sarcoma	0.000157	0.000363	CcSEcCtD
Aripiprazole—Agranulocytosis—Doxorubicin—sarcoma	0.000156	0.000362	CcSEcCtD
Aripiprazole—Rash—Mitoxantrone—sarcoma	0.000156	0.000362	CcSEcCtD
Aripiprazole—Dermatitis—Mitoxantrone—sarcoma	0.000156	0.000362	CcSEcCtD
Aripiprazole—Headache—Mitoxantrone—sarcoma	0.000155	0.00036	CcSEcCtD
Aripiprazole—Bradycardia—Doxorubicin—sarcoma	0.000153	0.000355	CcSEcCtD
Aripiprazole—Eye disorder—Epirubicin—sarcoma	0.000152	0.000352	CcSEcCtD
Aripiprazole—Hypersensitivity—Etoposide—sarcoma	0.000152	0.000352	CcSEcCtD
Aripiprazole—Tinnitus—Epirubicin—sarcoma	0.000151	0.000351	CcSEcCtD
Aripiprazole—Haemoglobin—Doxorubicin—sarcoma	0.000151	0.00035	CcSEcCtD
Aripiprazole—Nausea—Vincristine—sarcoma	0.000151	0.00035	CcSEcCtD
Aripiprazole—Cardiac disorder—Epirubicin—sarcoma	0.000151	0.00035	CcSEcCtD
Aripiprazole—Flushing—Epirubicin—sarcoma	0.000151	0.00035	CcSEcCtD
Aripiprazole—Rhinitis—Doxorubicin—sarcoma	0.000151	0.00035	CcSEcCtD
Aripiprazole—Haemorrhage—Doxorubicin—sarcoma	0.00015	0.000349	CcSEcCtD
Aripiprazole—Hepatitis—Doxorubicin—sarcoma	0.00015	0.000349	CcSEcCtD
Aripiprazole—Hypoaesthesia—Doxorubicin—sarcoma	0.00015	0.000347	CcSEcCtD
Aripiprazole—Pharyngitis—Doxorubicin—sarcoma	0.000149	0.000346	CcSEcCtD
Aripiprazole—Urinary tract disorder—Doxorubicin—sarcoma	0.000148	0.000344	CcSEcCtD
Aripiprazole—Oedema peripheral—Doxorubicin—sarcoma	0.000148	0.000343	CcSEcCtD
Aripiprazole—Asthenia—Etoposide—sarcoma	0.000148	0.000343	CcSEcCtD
Aripiprazole—Connective tissue disorder—Doxorubicin—sarcoma	0.000148	0.000343	CcSEcCtD
Aripiprazole—Angiopathy—Epirubicin—sarcoma	0.000147	0.000342	CcSEcCtD
Aripiprazole—Urethral disorder—Doxorubicin—sarcoma	0.000147	0.000342	CcSEcCtD
Aripiprazole—Nausea—Mitoxantrone—sarcoma	0.000147	0.000341	CcSEcCtD
Aripiprazole—Immune system disorder—Epirubicin—sarcoma	0.000147	0.00034	CcSEcCtD
Aripiprazole—Mediastinal disorder—Epirubicin—sarcoma	0.000146	0.00034	CcSEcCtD
Aripiprazole—Chills—Epirubicin—sarcoma	0.000146	0.000338	CcSEcCtD
Aripiprazole—Pruritus—Etoposide—sarcoma	0.000146	0.000338	CcSEcCtD
Aripiprazole—ABCB1—lymph node—sarcoma	0.000145	0.000933	CbGeAlD
Aripiprazole—Visual impairment—Doxorubicin—sarcoma	0.000145	0.000336	CcSEcCtD
Aripiprazole—Alopecia—Epirubicin—sarcoma	0.000144	0.000333	CcSEcCtD
Aripiprazole—Mental disorder—Epirubicin—sarcoma	0.000142	0.00033	CcSEcCtD
Aripiprazole—Erythema—Epirubicin—sarcoma	0.000141	0.000328	CcSEcCtD
Aripiprazole—Malnutrition—Epirubicin—sarcoma	0.000141	0.000328	CcSEcCtD
Aripiprazole—Diarrhoea—Etoposide—sarcoma	0.000141	0.000327	CcSEcCtD
Aripiprazole—Eye disorder—Doxorubicin—sarcoma	0.00014	0.000326	CcSEcCtD
Aripiprazole—Tinnitus—Doxorubicin—sarcoma	0.00014	0.000325	CcSEcCtD
Aripiprazole—Cardiac disorder—Doxorubicin—sarcoma	0.000139	0.000324	CcSEcCtD
Aripiprazole—Flushing—Doxorubicin—sarcoma	0.000139	0.000324	CcSEcCtD
Aripiprazole—Flatulence—Epirubicin—sarcoma	0.000139	0.000323	CcSEcCtD
Aripiprazole—Tension—Epirubicin—sarcoma	0.000139	0.000322	CcSEcCtD
Aripiprazole—Dysgeusia—Epirubicin—sarcoma	0.000138	0.000321	CcSEcCtD
Aripiprazole—Nervousness—Epirubicin—sarcoma	0.000137	0.000319	CcSEcCtD
Aripiprazole—Back pain—Epirubicin—sarcoma	0.000137	0.000317	CcSEcCtD
Aripiprazole—Angiopathy—Doxorubicin—sarcoma	0.000136	0.000316	CcSEcCtD
Aripiprazole—Dizziness—Etoposide—sarcoma	0.000136	0.000316	CcSEcCtD
Aripiprazole—Muscle spasms—Epirubicin—sarcoma	0.000136	0.000315	CcSEcCtD
Aripiprazole—Immune system disorder—Doxorubicin—sarcoma	0.000136	0.000315	CcSEcCtD
Aripiprazole—Mediastinal disorder—Doxorubicin—sarcoma	0.000135	0.000314	CcSEcCtD
Aripiprazole—Chills—Doxorubicin—sarcoma	0.000135	0.000313	CcSEcCtD
Aripiprazole—Vision blurred—Epirubicin—sarcoma	0.000133	0.000309	CcSEcCtD
Aripiprazole—Alopecia—Doxorubicin—sarcoma	0.000133	0.000308	CcSEcCtD
Aripiprazole—Mental disorder—Doxorubicin—sarcoma	0.000132	0.000305	CcSEcCtD
Aripiprazole—Ill-defined disorder—Epirubicin—sarcoma	0.000131	0.000304	CcSEcCtD
Aripiprazole—Vomiting—Etoposide—sarcoma	0.000131	0.000304	CcSEcCtD
Aripiprazole—Malnutrition—Doxorubicin—sarcoma	0.000131	0.000304	CcSEcCtD
Aripiprazole—Erythema—Doxorubicin—sarcoma	0.000131	0.000304	CcSEcCtD
Aripiprazole—Anaemia—Epirubicin—sarcoma	0.000131	0.000303	CcSEcCtD
Aripiprazole—Agitation—Epirubicin—sarcoma	0.00013	0.000301	CcSEcCtD
Aripiprazole—Rash—Etoposide—sarcoma	0.00013	0.000301	CcSEcCtD
Aripiprazole—Dermatitis—Etoposide—sarcoma	0.00013	0.000301	CcSEcCtD
Aripiprazole—Headache—Etoposide—sarcoma	0.000129	0.000299	CcSEcCtD
Aripiprazole—Flatulence—Doxorubicin—sarcoma	0.000129	0.000299	CcSEcCtD
Aripiprazole—Tension—Doxorubicin—sarcoma	0.000128	0.000298	CcSEcCtD
Aripiprazole—Dysgeusia—Doxorubicin—sarcoma	0.000128	0.000297	CcSEcCtD
Aripiprazole—Malaise—Epirubicin—sarcoma	0.000128	0.000296	CcSEcCtD
Aripiprazole—Nervousness—Doxorubicin—sarcoma	0.000127	0.000295	CcSEcCtD
Aripiprazole—Vertigo—Epirubicin—sarcoma	0.000127	0.000295	CcSEcCtD
Aripiprazole—Syncope—Epirubicin—sarcoma	0.000127	0.000294	CcSEcCtD
Aripiprazole—Leukopenia—Epirubicin—sarcoma	0.000127	0.000294	CcSEcCtD
Aripiprazole—Back pain—Doxorubicin—sarcoma	0.000127	0.000294	CcSEcCtD
Aripiprazole—Muscle spasms—Doxorubicin—sarcoma	0.000126	0.000292	CcSEcCtD
Aripiprazole—Palpitations—Epirubicin—sarcoma	0.000125	0.00029	CcSEcCtD
Aripiprazole—Loss of consciousness—Epirubicin—sarcoma	0.000124	0.000288	CcSEcCtD
Aripiprazole—Cough—Epirubicin—sarcoma	0.000123	0.000286	CcSEcCtD
Aripiprazole—Vision blurred—Doxorubicin—sarcoma	0.000123	0.000286	CcSEcCtD
Aripiprazole—Convulsion—Epirubicin—sarcoma	0.000123	0.000284	CcSEcCtD
Aripiprazole—Nausea—Etoposide—sarcoma	0.000122	0.000284	CcSEcCtD
Aripiprazole—Hypertension—Epirubicin—sarcoma	0.000122	0.000283	CcSEcCtD
Aripiprazole—Ill-defined disorder—Doxorubicin—sarcoma	0.000121	0.000282	CcSEcCtD
Aripiprazole—Anaemia—Doxorubicin—sarcoma	0.000121	0.000281	CcSEcCtD
Aripiprazole—Arthralgia—Epirubicin—sarcoma	0.00012	0.000279	CcSEcCtD
Aripiprazole—Chest pain—Epirubicin—sarcoma	0.00012	0.000279	CcSEcCtD
Aripiprazole—Myalgia—Epirubicin—sarcoma	0.00012	0.000279	CcSEcCtD
Aripiprazole—Agitation—Doxorubicin—sarcoma	0.00012	0.000279	CcSEcCtD
Aripiprazole—Anxiety—Epirubicin—sarcoma	0.00012	0.000278	CcSEcCtD
Aripiprazole—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—sarcoma	0.00012	0.000277	CcSEcCtD
Aripiprazole—Discomfort—Epirubicin—sarcoma	0.000119	0.000276	CcSEcCtD
Aripiprazole—Malaise—Doxorubicin—sarcoma	0.000118	0.000274	CcSEcCtD
Aripiprazole—Dry mouth—Epirubicin—sarcoma	0.000118	0.000273	CcSEcCtD
Aripiprazole—Vertigo—Doxorubicin—sarcoma	0.000118	0.000273	CcSEcCtD
Aripiprazole—Syncope—Doxorubicin—sarcoma	0.000117	0.000272	CcSEcCtD
Aripiprazole—Leukopenia—Doxorubicin—sarcoma	0.000117	0.000272	CcSEcCtD
Aripiprazole—Confusional state—Epirubicin—sarcoma	0.000116	0.00027	CcSEcCtD
Aripiprazole—Palpitations—Doxorubicin—sarcoma	0.000116	0.000268	CcSEcCtD
Aripiprazole—Anaphylactic shock—Epirubicin—sarcoma	0.000115	0.000268	CcSEcCtD
Aripiprazole—Oedema—Epirubicin—sarcoma	0.000115	0.000268	CcSEcCtD
Aripiprazole—Loss of consciousness—Doxorubicin—sarcoma	0.000115	0.000267	CcSEcCtD
Aripiprazole—Infection—Epirubicin—sarcoma	0.000115	0.000266	CcSEcCtD
Aripiprazole—Cough—Doxorubicin—sarcoma	0.000114	0.000265	CcSEcCtD
Aripiprazole—Shock—Epirubicin—sarcoma	0.000114	0.000263	CcSEcCtD
Aripiprazole—Convulsion—Doxorubicin—sarcoma	0.000113	0.000263	CcSEcCtD
Aripiprazole—Nervous system disorder—Epirubicin—sarcoma	0.000113	0.000263	CcSEcCtD
Aripiprazole—Thrombocytopenia—Epirubicin—sarcoma	0.000113	0.000262	CcSEcCtD
Aripiprazole—Hypertension—Doxorubicin—sarcoma	0.000113	0.000262	CcSEcCtD
Aripiprazole—Tachycardia—Epirubicin—sarcoma	0.000113	0.000261	CcSEcCtD
Aripiprazole—Skin disorder—Epirubicin—sarcoma	0.000112	0.00026	CcSEcCtD
Aripiprazole—Hyperhidrosis—Epirubicin—sarcoma	0.000112	0.000259	CcSEcCtD
Aripiprazole—Myalgia—Doxorubicin—sarcoma	0.000111	0.000258	CcSEcCtD
Aripiprazole—Arthralgia—Doxorubicin—sarcoma	0.000111	0.000258	CcSEcCtD
Aripiprazole—Chest pain—Doxorubicin—sarcoma	0.000111	0.000258	CcSEcCtD
Aripiprazole—Anxiety—Doxorubicin—sarcoma	0.000111	0.000258	CcSEcCtD
Aripiprazole—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—sarcoma	0.000111	0.000257	CcSEcCtD
Aripiprazole—Discomfort—Doxorubicin—sarcoma	0.00011	0.000255	CcSEcCtD
Aripiprazole—Anorexia—Epirubicin—sarcoma	0.00011	0.000255	CcSEcCtD
Aripiprazole—Dry mouth—Doxorubicin—sarcoma	0.000109	0.000253	CcSEcCtD
Aripiprazole—Hypotension—Epirubicin—sarcoma	0.000108	0.00025	CcSEcCtD
Aripiprazole—Confusional state—Doxorubicin—sarcoma	0.000108	0.00025	CcSEcCtD
Aripiprazole—Anaphylactic shock—Doxorubicin—sarcoma	0.000107	0.000248	CcSEcCtD
Aripiprazole—Oedema—Doxorubicin—sarcoma	0.000107	0.000248	CcSEcCtD
Aripiprazole—Infection—Doxorubicin—sarcoma	0.000106	0.000246	CcSEcCtD
Aripiprazole—Musculoskeletal discomfort—Epirubicin—sarcoma	0.000105	0.000244	CcSEcCtD
Aripiprazole—Shock—Doxorubicin—sarcoma	0.000105	0.000244	CcSEcCtD
Aripiprazole—Nervous system disorder—Doxorubicin—sarcoma	0.000105	0.000243	CcSEcCtD
Aripiprazole—Thrombocytopenia—Doxorubicin—sarcoma	0.000105	0.000243	CcSEcCtD
Aripiprazole—Insomnia—Epirubicin—sarcoma	0.000104	0.000242	CcSEcCtD
Aripiprazole—Tachycardia—Doxorubicin—sarcoma	0.000104	0.000242	CcSEcCtD
Aripiprazole—Skin disorder—Doxorubicin—sarcoma	0.000104	0.000241	CcSEcCtD
Aripiprazole—Paraesthesia—Epirubicin—sarcoma	0.000104	0.00024	CcSEcCtD
Aripiprazole—Hyperhidrosis—Doxorubicin—sarcoma	0.000103	0.000239	CcSEcCtD
Aripiprazole—Dyspnoea—Epirubicin—sarcoma	0.000103	0.000239	CcSEcCtD
Aripiprazole—Somnolence—Epirubicin—sarcoma	0.000103	0.000238	CcSEcCtD
Aripiprazole—Anorexia—Doxorubicin—sarcoma	0.000102	0.000236	CcSEcCtD
Aripiprazole—Dyspepsia—Epirubicin—sarcoma	0.000102	0.000236	CcSEcCtD
Aripiprazole—Decreased appetite—Epirubicin—sarcoma	0.0001	0.000233	CcSEcCtD
Aripiprazole—Hypotension—Doxorubicin—sarcoma	9.98e-05	0.000231	CcSEcCtD
Aripiprazole—Gastrointestinal disorder—Epirubicin—sarcoma	9.96e-05	0.000231	CcSEcCtD
Aripiprazole—Fatigue—Epirubicin—sarcoma	9.95e-05	0.000231	CcSEcCtD
Aripiprazole—Pain—Epirubicin—sarcoma	9.87e-05	0.000229	CcSEcCtD
Aripiprazole—Constipation—Epirubicin—sarcoma	9.87e-05	0.000229	CcSEcCtD
Aripiprazole—Musculoskeletal discomfort—Doxorubicin—sarcoma	9.73e-05	0.000226	CcSEcCtD
Aripiprazole—Insomnia—Doxorubicin—sarcoma	9.66e-05	0.000224	CcSEcCtD
Aripiprazole—Paraesthesia—Doxorubicin—sarcoma	9.59e-05	0.000222	CcSEcCtD
Aripiprazole—Dyspnoea—Doxorubicin—sarcoma	9.52e-05	0.000221	CcSEcCtD
Aripiprazole—Feeling abnormal—Epirubicin—sarcoma	9.51e-05	0.000221	CcSEcCtD
Aripiprazole—Somnolence—Doxorubicin—sarcoma	9.49e-05	0.00022	CcSEcCtD
Aripiprazole—Gastrointestinal pain—Epirubicin—sarcoma	9.44e-05	0.000219	CcSEcCtD
Aripiprazole—Dyspepsia—Doxorubicin—sarcoma	9.4e-05	0.000218	CcSEcCtD
Aripiprazole—Decreased appetite—Doxorubicin—sarcoma	9.28e-05	0.000215	CcSEcCtD
Aripiprazole—Gastrointestinal disorder—Doxorubicin—sarcoma	9.22e-05	0.000214	CcSEcCtD
Aripiprazole—Fatigue—Doxorubicin—sarcoma	9.21e-05	0.000214	CcSEcCtD
Aripiprazole—Urticaria—Epirubicin—sarcoma	9.17e-05	0.000213	CcSEcCtD
Aripiprazole—Pain—Doxorubicin—sarcoma	9.13e-05	0.000212	CcSEcCtD
Aripiprazole—Constipation—Doxorubicin—sarcoma	9.13e-05	0.000212	CcSEcCtD
Aripiprazole—Abdominal pain—Epirubicin—sarcoma	9.12e-05	0.000212	CcSEcCtD
Aripiprazole—Body temperature increased—Epirubicin—sarcoma	9.12e-05	0.000212	CcSEcCtD
Aripiprazole—Feeling abnormal—Doxorubicin—sarcoma	8.8e-05	0.000204	CcSEcCtD
Aripiprazole—Gastrointestinal pain—Doxorubicin—sarcoma	8.73e-05	0.000203	CcSEcCtD
Aripiprazole—Hypersensitivity—Epirubicin—sarcoma	8.5e-05	0.000197	CcSEcCtD
Aripiprazole—Urticaria—Doxorubicin—sarcoma	8.48e-05	0.000197	CcSEcCtD
Aripiprazole—Abdominal pain—Doxorubicin—sarcoma	8.44e-05	0.000196	CcSEcCtD
Aripiprazole—Body temperature increased—Doxorubicin—sarcoma	8.44e-05	0.000196	CcSEcCtD
Aripiprazole—Asthenia—Epirubicin—sarcoma	8.28e-05	0.000192	CcSEcCtD
Aripiprazole—Pruritus—Epirubicin—sarcoma	8.17e-05	0.000189	CcSEcCtD
Aripiprazole—Diarrhoea—Epirubicin—sarcoma	7.9e-05	0.000183	CcSEcCtD
Aripiprazole—Hypersensitivity—Doxorubicin—sarcoma	7.87e-05	0.000183	CcSEcCtD
Aripiprazole—Asthenia—Doxorubicin—sarcoma	7.66e-05	0.000178	CcSEcCtD
Aripiprazole—Dizziness—Epirubicin—sarcoma	7.63e-05	0.000177	CcSEcCtD
Aripiprazole—Pruritus—Doxorubicin—sarcoma	7.56e-05	0.000175	CcSEcCtD
Aripiprazole—Vomiting—Epirubicin—sarcoma	7.34e-05	0.00017	CcSEcCtD
Aripiprazole—Diarrhoea—Doxorubicin—sarcoma	7.31e-05	0.000169	CcSEcCtD
Aripiprazole—Rash—Epirubicin—sarcoma	7.28e-05	0.000169	CcSEcCtD
Aripiprazole—Dermatitis—Epirubicin—sarcoma	7.27e-05	0.000169	CcSEcCtD
Aripiprazole—Headache—Epirubicin—sarcoma	7.23e-05	0.000168	CcSEcCtD
Aripiprazole—Dizziness—Doxorubicin—sarcoma	7.06e-05	0.000164	CcSEcCtD
Aripiprazole—Nausea—Epirubicin—sarcoma	6.86e-05	0.000159	CcSEcCtD
Aripiprazole—Vomiting—Doxorubicin—sarcoma	6.79e-05	0.000158	CcSEcCtD
Aripiprazole—Rash—Doxorubicin—sarcoma	6.73e-05	0.000156	CcSEcCtD
Aripiprazole—Dermatitis—Doxorubicin—sarcoma	6.73e-05	0.000156	CcSEcCtD
Aripiprazole—Headache—Doxorubicin—sarcoma	6.69e-05	0.000155	CcSEcCtD
Aripiprazole—Nausea—Doxorubicin—sarcoma	6.34e-05	0.000147	CcSEcCtD
Aripiprazole—HTR2B—Signaling Pathways—VEGFA—sarcoma	5.74e-06	0.000152	CbGpPWpGaD
Aripiprazole—CHRM3—Signaling by GPCR—KRAS—sarcoma	5.73e-06	0.000152	CbGpPWpGaD
Aripiprazole—ADRB1—Signaling Pathways—IL2—sarcoma	5.72e-06	0.000152	CbGpPWpGaD
Aripiprazole—HTR1A—Signaling by GPCR—HRAS—sarcoma	5.69e-06	0.000151	CbGpPWpGaD
Aripiprazole—CHRM2—Signaling by GPCR—KRAS—sarcoma	5.68e-06	0.000151	CbGpPWpGaD
Aripiprazole—CHRM5—Signaling Pathways—VEGFA—sarcoma	5.68e-06	0.00015	CbGpPWpGaD
Aripiprazole—ADRA2B—Signaling Pathways—IL2—sarcoma	5.67e-06	0.00015	CbGpPWpGaD
Aripiprazole—HTR2B—Signaling Pathways—NRAS—sarcoma	5.67e-06	0.00015	CbGpPWpGaD
Aripiprazole—ADRA1A—Signaling by GPCR—KRAS—sarcoma	5.66e-06	0.00015	CbGpPWpGaD
Aripiprazole—HTR2C—Signaling by GPCR—HRAS—sarcoma	5.66e-06	0.00015	CbGpPWpGaD
Aripiprazole—HTR6—Signaling Pathways—EGFR—sarcoma	5.66e-06	0.00015	CbGpPWpGaD
Aripiprazole—HTR7—Signaling Pathways—EGFR—sarcoma	5.65e-06	0.00015	CbGpPWpGaD
Aripiprazole—HTR1B—Signaling Pathways—MYC—sarcoma	5.62e-06	0.000149	CbGpPWpGaD
Aripiprazole—HTR1D—Signaling Pathways—EGFR—sarcoma	5.61e-06	0.000149	CbGpPWpGaD
Aripiprazole—CHRM5—Signaling Pathways—NRAS—sarcoma	5.61e-06	0.000149	CbGpPWpGaD
Aripiprazole—ADRB1—Signaling Pathways—CCND1—sarcoma	5.58e-06	0.000148	CbGpPWpGaD
Aripiprazole—ADRA2A—Signaling by GPCR—EGFR—sarcoma	5.57e-06	0.000148	CbGpPWpGaD
Aripiprazole—ADRB1—Signaling Pathways—JUN—sarcoma	5.57e-06	0.000148	CbGpPWpGaD
Aripiprazole—DRD1—Signaling Pathways—SRC—sarcoma	5.55e-06	0.000147	CbGpPWpGaD
Aripiprazole—DRD4—Signaling Pathways—MYC—sarcoma	5.53e-06	0.000147	CbGpPWpGaD
Aripiprazole—ADRA2B—Signaling Pathways—CCND1—sarcoma	5.53e-06	0.000147	CbGpPWpGaD
Aripiprazole—ADRB1—Signaling Pathways—CTNNB1—sarcoma	5.52e-06	0.000146	CbGpPWpGaD
Aripiprazole—ADRA2B—Signaling Pathways—JUN—sarcoma	5.52e-06	0.000146	CbGpPWpGaD
Aripiprazole—ADRA2C—Signaling by GPCR—HRAS—sarcoma	5.51e-06	0.000146	CbGpPWpGaD
Aripiprazole—HTR1B—Signaling Pathways—EGFR—sarcoma	5.5e-06	0.000146	CbGpPWpGaD
Aripiprazole—DRD3—Signaling Pathways—SRC—sarcoma	5.48e-06	0.000145	CbGpPWpGaD
Aripiprazole—ADRA2B—Signaling Pathways—CTNNB1—sarcoma	5.47e-06	0.000145	CbGpPWpGaD
Aripiprazole—HTR1A—Signaling Pathways—IL2—sarcoma	5.47e-06	0.000145	CbGpPWpGaD
Aripiprazole—CHRM4—Signaling Pathways—MYC—sarcoma	5.45e-06	0.000145	CbGpPWpGaD
Aripiprazole—HTR2C—Signaling Pathways—IL2—sarcoma	5.45e-06	0.000144	CbGpPWpGaD
Aripiprazole—ADRA1B—Signaling by GPCR—HRAS—sarcoma	5.42e-06	0.000144	CbGpPWpGaD
Aripiprazole—DRD1—Signaling Pathways—VEGFA—sarcoma	5.41e-06	0.000143	CbGpPWpGaD
Aripiprazole—DRD4—Signaling Pathways—EGFR—sarcoma	5.41e-06	0.000143	CbGpPWpGaD
Aripiprazole—DRD2—Signaling Pathways—MDM2—sarcoma	5.38e-06	0.000143	CbGpPWpGaD
Aripiprazole—DRD1—Signaling Pathways—NRAS—sarcoma	5.34e-06	0.000142	CbGpPWpGaD
Aripiprazole—HTR6—Signaling Pathways—KRAS—sarcoma	5.34e-06	0.000142	CbGpPWpGaD
Aripiprazole—DRD3—Signaling Pathways—VEGFA—sarcoma	5.34e-06	0.000141	CbGpPWpGaD
Aripiprazole—HTR7—Signaling Pathways—KRAS—sarcoma	5.34e-06	0.000141	CbGpPWpGaD
Aripiprazole—HTR1A—Signaling Pathways—CCND1—sarcoma	5.34e-06	0.000141	CbGpPWpGaD
Aripiprazole—CHRM4—Signaling Pathways—EGFR—sarcoma	5.34e-06	0.000141	CbGpPWpGaD
Aripiprazole—HTR1A—Signaling Pathways—JUN—sarcoma	5.32e-06	0.000141	CbGpPWpGaD
Aripiprazole—HTR2C—Signaling Pathways—CCND1—sarcoma	5.31e-06	0.000141	CbGpPWpGaD
Aripiprazole—HTR1D—Signaling Pathways—KRAS—sarcoma	5.3e-06	0.000141	CbGpPWpGaD
Aripiprazole—HTR2C—Signaling Pathways—JUN—sarcoma	5.3e-06	0.00014	CbGpPWpGaD
Aripiprazole—ADRA2C—Signaling Pathways—IL2—sarcoma	5.3e-06	0.00014	CbGpPWpGaD
Aripiprazole—HTR2A—Signaling Pathways—MDM2—sarcoma	5.29e-06	0.00014	CbGpPWpGaD
Aripiprazole—HTR1A—Signaling Pathways—CTNNB1—sarcoma	5.28e-06	0.00014	CbGpPWpGaD
Aripiprazole—HRH1—Signaling Pathways—MDM2—sarcoma	5.28e-06	0.00014	CbGpPWpGaD
Aripiprazole—HTR2B—Signaling Pathways—MYC—sarcoma	5.28e-06	0.00014	CbGpPWpGaD
Aripiprazole—DRD3—Signaling Pathways—NRAS—sarcoma	5.27e-06	0.00014	CbGpPWpGaD
Aripiprazole—CHRM1—Signaling Pathways—MDM2—sarcoma	5.26e-06	0.00014	CbGpPWpGaD
Aripiprazole—ADRA2A—Signaling by GPCR—KRAS—sarcoma	5.26e-06	0.000139	CbGpPWpGaD
Aripiprazole—HTR2C—Signaling Pathways—CTNNB1—sarcoma	5.26e-06	0.000139	CbGpPWpGaD
Aripiprazole—CHRM3—Signaling Pathways—MDM2—sarcoma	5.25e-06	0.000139	CbGpPWpGaD
Aripiprazole—CHRM5—Signaling Pathways—MYC—sarcoma	5.22e-06	0.000138	CbGpPWpGaD
Aripiprazole—ADRA1B—Signaling Pathways—IL2—sarcoma	5.21e-06	0.000138	CbGpPWpGaD
Aripiprazole—CHRM2—Signaling Pathways—MDM2—sarcoma	5.2e-06	0.000138	CbGpPWpGaD
Aripiprazole—HTR1B—Signaling Pathways—KRAS—sarcoma	5.19e-06	0.000138	CbGpPWpGaD
Aripiprazole—ADRA1A—Signaling Pathways—MDM2—sarcoma	5.18e-06	0.000137	CbGpPWpGaD
Aripiprazole—ADRA2C—Signaling Pathways—CCND1—sarcoma	5.16e-06	0.000137	CbGpPWpGaD
Aripiprazole—HTR2B—Signaling Pathways—EGFR—sarcoma	5.16e-06	0.000137	CbGpPWpGaD
Aripiprazole—ADRA2C—Signaling Pathways—JUN—sarcoma	5.15e-06	0.000137	CbGpPWpGaD
Aripiprazole—ADRA2C—Signaling Pathways—CTNNB1—sarcoma	5.11e-06	0.000136	CbGpPWpGaD
Aripiprazole—CHRM5—Signaling Pathways—EGFR—sarcoma	5.11e-06	0.000135	CbGpPWpGaD
Aripiprazole—DRD4—Signaling Pathways—KRAS—sarcoma	5.11e-06	0.000135	CbGpPWpGaD
Aripiprazole—ADRA1B—Signaling Pathways—CCND1—sarcoma	5.08e-06	0.000135	CbGpPWpGaD
Aripiprazole—ADRA1B—Signaling Pathways—JUN—sarcoma	5.07e-06	0.000134	CbGpPWpGaD
Aripiprazole—CHRM4—Signaling Pathways—KRAS—sarcoma	5.04e-06	0.000134	CbGpPWpGaD
Aripiprazole—ADRA1B—Signaling Pathways—CTNNB1—sarcoma	5.03e-06	0.000133	CbGpPWpGaD
Aripiprazole—DRD2—Signaling by GPCR—HRAS—sarcoma	5e-06	0.000132	CbGpPWpGaD
Aripiprazole—ADRB1—Signaling Pathways—SRC—sarcoma	4.99e-06	0.000132	CbGpPWpGaD
Aripiprazole—DRD1—Signaling Pathways—MYC—sarcoma	4.98e-06	0.000132	CbGpPWpGaD
Aripiprazole—ADRA2B—Signaling Pathways—SRC—sarcoma	4.95e-06	0.000131	CbGpPWpGaD
Aripiprazole—HTR2A—Signaling by GPCR—HRAS—sarcoma	4.92e-06	0.00013	CbGpPWpGaD
Aripiprazole—DRD3—Signaling Pathways—MYC—sarcoma	4.91e-06	0.00013	CbGpPWpGaD
Aripiprazole—HRH1—Signaling by GPCR—HRAS—sarcoma	4.91e-06	0.00013	CbGpPWpGaD
Aripiprazole—CHRM1—Signaling by GPCR—HRAS—sarcoma	4.89e-06	0.00013	CbGpPWpGaD
Aripiprazole—HTR2B—Signaling Pathways—KRAS—sarcoma	4.88e-06	0.000129	CbGpPWpGaD
Aripiprazole—CHRM3—Signaling by GPCR—HRAS—sarcoma	4.87e-06	0.000129	CbGpPWpGaD
Aripiprazole—DRD1—Signaling Pathways—EGFR—sarcoma	4.87e-06	0.000129	CbGpPWpGaD
Aripiprazole—ADRB1—Signaling Pathways—VEGFA—sarcoma	4.86e-06	0.000129	CbGpPWpGaD
Aripiprazole—CHRM2—Signaling by GPCR—HRAS—sarcoma	4.83e-06	0.000128	CbGpPWpGaD
Aripiprazole—CHRM5—Signaling Pathways—KRAS—sarcoma	4.83e-06	0.000128	CbGpPWpGaD
Aripiprazole—ADRA2B—Signaling Pathways—VEGFA—sarcoma	4.82e-06	0.000128	CbGpPWpGaD
Aripiprazole—ADRA2A—Signaling Pathways—MDM2—sarcoma	4.81e-06	0.000128	CbGpPWpGaD
Aripiprazole—ADRA1A—Signaling by GPCR—HRAS—sarcoma	4.81e-06	0.000128	CbGpPWpGaD
Aripiprazole—DRD2—Signaling Pathways—IL2—sarcoma	4.81e-06	0.000127	CbGpPWpGaD
Aripiprazole—ADRB1—Signaling Pathways—NRAS—sarcoma	4.8e-06	0.000127	CbGpPWpGaD
Aripiprazole—DRD3—Signaling Pathways—EGFR—sarcoma	4.8e-06	0.000127	CbGpPWpGaD
Aripiprazole—HTR1A—Signaling Pathways—SRC—sarcoma	4.78e-06	0.000127	CbGpPWpGaD
Aripiprazole—ADRA2B—Signaling Pathways—NRAS—sarcoma	4.76e-06	0.000126	CbGpPWpGaD
Aripiprazole—HTR2C—Signaling Pathways—SRC—sarcoma	4.75e-06	0.000126	CbGpPWpGaD
Aripiprazole—HTR6—Signaling Pathways—TP53—sarcoma	4.75e-06	0.000126	CbGpPWpGaD
Aripiprazole—HTR7—Signaling Pathways—TP53—sarcoma	4.74e-06	0.000126	CbGpPWpGaD
Aripiprazole—HTR2A—Signaling Pathways—IL2—sarcoma	4.73e-06	0.000125	CbGpPWpGaD
Aripiprazole—HRH1—Signaling Pathways—IL2—sarcoma	4.72e-06	0.000125	CbGpPWpGaD
Aripiprazole—HTR1D—Signaling Pathways—TP53—sarcoma	4.71e-06	0.000125	CbGpPWpGaD
Aripiprazole—CHRM1—Signaling Pathways—IL2—sarcoma	4.7e-06	0.000125	CbGpPWpGaD
Aripiprazole—CHRM3—Signaling Pathways—IL2—sarcoma	4.69e-06	0.000124	CbGpPWpGaD
Aripiprazole—DRD2—Signaling Pathways—CCND1—sarcoma	4.69e-06	0.000124	CbGpPWpGaD
Aripiprazole—DRD2—Signaling Pathways—JUN—sarcoma	4.68e-06	0.000124	CbGpPWpGaD
Aripiprazole—HTR1A—Signaling Pathways—VEGFA—sarcoma	4.65e-06	0.000123	CbGpPWpGaD
Aripiprazole—CHRM2—Signaling Pathways—IL2—sarcoma	4.64e-06	0.000123	CbGpPWpGaD
Aripiprazole—DRD2—Signaling Pathways—CTNNB1—sarcoma	4.64e-06	0.000123	CbGpPWpGaD
Aripiprazole—ADRA1A—Signaling Pathways—IL2—sarcoma	4.63e-06	0.000123	CbGpPWpGaD
Aripiprazole—HTR2C—Signaling Pathways—VEGFA—sarcoma	4.63e-06	0.000123	CbGpPWpGaD
Aripiprazole—ADRA2C—Signaling Pathways—SRC—sarcoma	4.62e-06	0.000122	CbGpPWpGaD
Aripiprazole—HTR1B—Signaling Pathways—TP53—sarcoma	4.61e-06	0.000122	CbGpPWpGaD
Aripiprazole—HTR2A—Signaling Pathways—CCND1—sarcoma	4.61e-06	0.000122	CbGpPWpGaD
Aripiprazole—HTR2A—Signaling Pathways—JUN—sarcoma	4.6e-06	0.000122	CbGpPWpGaD
Aripiprazole—HRH1—Signaling Pathways—CCND1—sarcoma	4.6e-06	0.000122	CbGpPWpGaD
Aripiprazole—DRD1—Signaling Pathways—KRAS—sarcoma	4.6e-06	0.000122	CbGpPWpGaD
Aripiprazole—HTR1A—Signaling Pathways—NRAS—sarcoma	4.59e-06	0.000122	CbGpPWpGaD
Aripiprazole—HRH1—Signaling Pathways—JUN—sarcoma	4.59e-06	0.000122	CbGpPWpGaD
Aripiprazole—CHRM1—Signaling Pathways—CCND1—sarcoma	4.59e-06	0.000122	CbGpPWpGaD
Aripiprazole—CHRM1—Signaling Pathways—JUN—sarcoma	4.58e-06	0.000121	CbGpPWpGaD
Aripiprazole—HTR2C—Signaling Pathways—NRAS—sarcoma	4.57e-06	0.000121	CbGpPWpGaD
Aripiprazole—CHRM3—Signaling Pathways—CCND1—sarcoma	4.57e-06	0.000121	CbGpPWpGaD
Aripiprazole—HTR2A—Signaling Pathways—CTNNB1—sarcoma	4.57e-06	0.000121	CbGpPWpGaD
Aripiprazole—CHRM3—Signaling Pathways—JUN—sarcoma	4.56e-06	0.000121	CbGpPWpGaD
Aripiprazole—HRH1—Signaling Pathways—CTNNB1—sarcoma	4.56e-06	0.000121	CbGpPWpGaD
Aripiprazole—ADRA1B—Signaling Pathways—SRC—sarcoma	4.55e-06	0.000121	CbGpPWpGaD
Aripiprazole—HTR6—Signaling Pathways—HRAS—sarcoma	4.54e-06	0.00012	CbGpPWpGaD
Aripiprazole—CHRM1—Signaling Pathways—CTNNB1—sarcoma	4.54e-06	0.00012	CbGpPWpGaD
Aripiprazole—DRD4—Signaling Pathways—TP53—sarcoma	4.54e-06	0.00012	CbGpPWpGaD
Aripiprazole—DRD3—Signaling Pathways—KRAS—sarcoma	4.54e-06	0.00012	CbGpPWpGaD
Aripiprazole—HTR7—Signaling Pathways—HRAS—sarcoma	4.54e-06	0.00012	CbGpPWpGaD
Aripiprazole—CHRM3—Signaling Pathways—CTNNB1—sarcoma	4.53e-06	0.00012	CbGpPWpGaD
Aripiprazole—CHRM2—Signaling Pathways—CCND1—sarcoma	4.53e-06	0.00012	CbGpPWpGaD
Aripiprazole—CHRM2—Signaling Pathways—JUN—sarcoma	4.52e-06	0.00012	CbGpPWpGaD
Aripiprazole—ADRA1A—Signaling Pathways—CCND1—sarcoma	4.51e-06	0.00012	CbGpPWpGaD
Aripiprazole—HTR1D—Signaling Pathways—HRAS—sarcoma	4.51e-06	0.000119	CbGpPWpGaD
Aripiprazole—ADRA1A—Signaling Pathways—JUN—sarcoma	4.5e-06	0.000119	CbGpPWpGaD
Aripiprazole—ADRA2C—Signaling Pathways—VEGFA—sarcoma	4.5e-06	0.000119	CbGpPWpGaD
Aripiprazole—CHRM2—Signaling Pathways—CTNNB1—sarcoma	4.48e-06	0.000119	CbGpPWpGaD
Aripiprazole—CHRM4—Signaling Pathways—TP53—sarcoma	4.48e-06	0.000119	CbGpPWpGaD
Aripiprazole—ADRB1—Signaling Pathways—MYC—sarcoma	4.47e-06	0.000119	CbGpPWpGaD
Aripiprazole—ADRA2A—Signaling by GPCR—HRAS—sarcoma	4.47e-06	0.000119	CbGpPWpGaD
Aripiprazole—ADRA1A—Signaling Pathways—CTNNB1—sarcoma	4.47e-06	0.000118	CbGpPWpGaD
Aripiprazole—ADRA2C—Signaling Pathways—NRAS—sarcoma	4.45e-06	0.000118	CbGpPWpGaD
Aripiprazole—ADRA2B—Signaling Pathways—MYC—sarcoma	4.43e-06	0.000118	CbGpPWpGaD
Aripiprazole—ADRA1B—Signaling Pathways—VEGFA—sarcoma	4.43e-06	0.000117	CbGpPWpGaD
Aripiprazole—HTR1B—Signaling Pathways—HRAS—sarcoma	4.41e-06	0.000117	CbGpPWpGaD
Aripiprazole—ADRB1—Signaling Pathways—EGFR—sarcoma	4.38e-06	0.000116	CbGpPWpGaD
Aripiprazole—ADRA1B—Signaling Pathways—NRAS—sarcoma	4.38e-06	0.000116	CbGpPWpGaD
Aripiprazole—DRD4—Signaling Pathways—HRAS—sarcoma	4.34e-06	0.000115	CbGpPWpGaD
Aripiprazole—ADRA2B—Signaling Pathways—EGFR—sarcoma	4.34e-06	0.000115	CbGpPWpGaD
Aripiprazole—HTR2B—Signaling Pathways—TP53—sarcoma	4.33e-06	0.000115	CbGpPWpGaD
Aripiprazole—ADRA2A—Signaling Pathways—IL2—sarcoma	4.3e-06	0.000114	CbGpPWpGaD
Aripiprazole—CHRM5—Signaling Pathways—TP53—sarcoma	4.29e-06	0.000114	CbGpPWpGaD
Aripiprazole—CHRM4—Signaling Pathways—HRAS—sarcoma	4.28e-06	0.000114	CbGpPWpGaD
Aripiprazole—HTR1A—Signaling Pathways—MYC—sarcoma	4.28e-06	0.000113	CbGpPWpGaD
Aripiprazole—HTR2C—Signaling Pathways—MYC—sarcoma	4.26e-06	0.000113	CbGpPWpGaD
Aripiprazole—ADRA2A—Signaling Pathways—CCND1—sarcoma	4.19e-06	0.000111	CbGpPWpGaD
Aripiprazole—DRD2—Signaling Pathways—SRC—sarcoma	4.19e-06	0.000111	CbGpPWpGaD
Aripiprazole—HTR1A—Signaling Pathways—EGFR—sarcoma	4.19e-06	0.000111	CbGpPWpGaD
Aripiprazole—ADRA2A—Signaling Pathways—JUN—sarcoma	4.19e-06	0.000111	CbGpPWpGaD
Aripiprazole—HTR2C—Signaling Pathways—EGFR—sarcoma	4.16e-06	0.00011	CbGpPWpGaD
Aripiprazole—ADRA2A—Signaling Pathways—CTNNB1—sarcoma	4.15e-06	0.00011	CbGpPWpGaD
Aripiprazole—HTR2B—Signaling Pathways—HRAS—sarcoma	4.15e-06	0.00011	CbGpPWpGaD
Aripiprazole—ADRA2C—Signaling Pathways—MYC—sarcoma	4.14e-06	0.00011	CbGpPWpGaD
Aripiprazole—ADRB1—Signaling Pathways—KRAS—sarcoma	4.13e-06	0.00011	CbGpPWpGaD
Aripiprazole—HTR2A—Signaling Pathways—SRC—sarcoma	4.13e-06	0.000109	CbGpPWpGaD
Aripiprazole—HRH1—Signaling Pathways—SRC—sarcoma	4.12e-06	0.000109	CbGpPWpGaD
Aripiprazole—CHRM1—Signaling Pathways—SRC—sarcoma	4.1e-06	0.000109	CbGpPWpGaD
Aripiprazole—CHRM5—Signaling Pathways—HRAS—sarcoma	4.1e-06	0.000109	CbGpPWpGaD
Aripiprazole—ADRA2B—Signaling Pathways—KRAS—sarcoma	4.1e-06	0.000109	CbGpPWpGaD
Aripiprazole—CHRM3—Signaling Pathways—SRC—sarcoma	4.09e-06	0.000108	CbGpPWpGaD
Aripiprazole—DRD1—Signaling Pathways—TP53—sarcoma	4.09e-06	0.000108	CbGpPWpGaD
Aripiprazole—DRD2—Signaling Pathways—VEGFA—sarcoma	4.08e-06	0.000108	CbGpPWpGaD
Aripiprazole—ADRA1B—Signaling Pathways—MYC—sarcoma	4.08e-06	0.000108	CbGpPWpGaD
Aripiprazole—CHRM2—Signaling Pathways—SRC—sarcoma	4.05e-06	0.000107	CbGpPWpGaD
Aripiprazole—ADRA2C—Signaling Pathways—EGFR—sarcoma	4.05e-06	0.000107	CbGpPWpGaD
Aripiprazole—ADRA1A—Signaling Pathways—SRC—sarcoma	4.04e-06	0.000107	CbGpPWpGaD
Aripiprazole—DRD2—Signaling Pathways—NRAS—sarcoma	4.03e-06	0.000107	CbGpPWpGaD
Aripiprazole—DRD3—Signaling Pathways—TP53—sarcoma	4.03e-06	0.000107	CbGpPWpGaD
Aripiprazole—HTR2A—Signaling Pathways—VEGFA—sarcoma	4.02e-06	0.000107	CbGpPWpGaD
Aripiprazole—HRH1—Signaling Pathways—VEGFA—sarcoma	4.01e-06	0.000106	CbGpPWpGaD
Aripiprazole—CHRM1—Signaling Pathways—VEGFA—sarcoma	4e-06	0.000106	CbGpPWpGaD
Aripiprazole—ADRA1B—Signaling Pathways—EGFR—sarcoma	3.99e-06	0.000106	CbGpPWpGaD
Aripiprazole—CHRM3—Signaling Pathways—VEGFA—sarcoma	3.98e-06	0.000106	CbGpPWpGaD
Aripiprazole—HTR2A—Signaling Pathways—NRAS—sarcoma	3.97e-06	0.000105	CbGpPWpGaD
Aripiprazole—HRH1—Signaling Pathways—NRAS—sarcoma	3.96e-06	0.000105	CbGpPWpGaD
Aripiprazole—HTR1A—Signaling Pathways—KRAS—sarcoma	3.95e-06	0.000105	CbGpPWpGaD
Aripiprazole—CHRM1—Signaling Pathways—NRAS—sarcoma	3.95e-06	0.000105	CbGpPWpGaD
Aripiprazole—CHRM2—Signaling Pathways—VEGFA—sarcoma	3.95e-06	0.000105	CbGpPWpGaD
Aripiprazole—CHRM3—Signaling Pathways—NRAS—sarcoma	3.94e-06	0.000104	CbGpPWpGaD
Aripiprazole—ADRA1A—Signaling Pathways—VEGFA—sarcoma	3.94e-06	0.000104	CbGpPWpGaD
Aripiprazole—HTR2C—Signaling Pathways—KRAS—sarcoma	3.93e-06	0.000104	CbGpPWpGaD
Aripiprazole—DRD1—Signaling Pathways—HRAS—sarcoma	3.91e-06	0.000104	CbGpPWpGaD
Aripiprazole—CHRM2—Signaling Pathways—NRAS—sarcoma	3.9e-06	0.000103	CbGpPWpGaD
Aripiprazole—ADRA1A—Signaling Pathways—NRAS—sarcoma	3.89e-06	0.000103	CbGpPWpGaD
Aripiprazole—DRD3—Signaling Pathways—HRAS—sarcoma	3.86e-06	0.000102	CbGpPWpGaD
Aripiprazole—ADRA2C—Signaling Pathways—KRAS—sarcoma	3.83e-06	0.000101	CbGpPWpGaD
Aripiprazole—ADRA1B—Signaling Pathways—KRAS—sarcoma	3.77e-06	9.98e-05	CbGpPWpGaD
Aripiprazole—DRD2—Signaling Pathways—MYC—sarcoma	3.76e-06	9.96e-05	CbGpPWpGaD
Aripiprazole—ADRA2A—Signaling Pathways—SRC—sarcoma	3.75e-06	9.95e-05	CbGpPWpGaD
Aripiprazole—HTR2A—Signaling Pathways—MYC—sarcoma	3.7e-06	9.8e-05	CbGpPWpGaD
Aripiprazole—HRH1—Signaling Pathways—MYC—sarcoma	3.69e-06	9.78e-05	CbGpPWpGaD
Aripiprazole—CHRM1—Signaling Pathways—MYC—sarcoma	3.68e-06	9.75e-05	CbGpPWpGaD
Aripiprazole—DRD2—Signaling Pathways—EGFR—sarcoma	3.68e-06	9.74e-05	CbGpPWpGaD
Aripiprazole—ADRB1—Signaling Pathways—TP53—sarcoma	3.67e-06	9.74e-05	CbGpPWpGaD
Aripiprazole—CHRM3—Signaling Pathways—MYC—sarcoma	3.67e-06	9.72e-05	CbGpPWpGaD
Aripiprazole—ADRA2A—Signaling Pathways—VEGFA—sarcoma	3.66e-06	9.69e-05	CbGpPWpGaD
Aripiprazole—ADRA2B—Signaling Pathways—TP53—sarcoma	3.64e-06	9.65e-05	CbGpPWpGaD
Aripiprazole—CHRM2—Signaling Pathways—MYC—sarcoma	3.63e-06	9.62e-05	CbGpPWpGaD
Aripiprazole—ADRA1A—Signaling Pathways—MYC—sarcoma	3.62e-06	9.6e-05	CbGpPWpGaD
Aripiprazole—HTR2A—Signaling Pathways—EGFR—sarcoma	3.62e-06	9.59e-05	CbGpPWpGaD
Aripiprazole—ADRA2A—Signaling Pathways—NRAS—sarcoma	3.61e-06	9.57e-05	CbGpPWpGaD
Aripiprazole—HRH1—Signaling Pathways—EGFR—sarcoma	3.61e-06	9.56e-05	CbGpPWpGaD
Aripiprazole—CHRM1—Signaling Pathways—EGFR—sarcoma	3.6e-06	9.53e-05	CbGpPWpGaD
Aripiprazole—CHRM3—Signaling Pathways—EGFR—sarcoma	3.59e-06	9.5e-05	CbGpPWpGaD
Aripiprazole—CHRM2—Signaling Pathways—EGFR—sarcoma	3.55e-06	9.41e-05	CbGpPWpGaD
Aripiprazole—ADRA1A—Signaling Pathways—EGFR—sarcoma	3.54e-06	9.39e-05	CbGpPWpGaD
Aripiprazole—HTR1A—Signaling Pathways—TP53—sarcoma	3.51e-06	9.32e-05	CbGpPWpGaD
Aripiprazole—ADRB1—Signaling Pathways—HRAS—sarcoma	3.51e-06	9.31e-05	CbGpPWpGaD
Aripiprazole—HTR2C—Signaling Pathways—TP53—sarcoma	3.5e-06	9.27e-05	CbGpPWpGaD
Aripiprazole—ADRA2B—Signaling Pathways—HRAS—sarcoma	3.48e-06	9.23e-05	CbGpPWpGaD
Aripiprazole—DRD2—Signaling Pathways—KRAS—sarcoma	3.47e-06	9.2e-05	CbGpPWpGaD
Aripiprazole—HTR2A—Signaling Pathways—KRAS—sarcoma	3.42e-06	9.06e-05	CbGpPWpGaD
Aripiprazole—HRH1—Signaling Pathways—KRAS—sarcoma	3.41e-06	9.04e-05	CbGpPWpGaD
Aripiprazole—ADRA2C—Signaling Pathways—TP53—sarcoma	3.4e-06	9.01e-05	CbGpPWpGaD
Aripiprazole—CHRM1—Signaling Pathways—KRAS—sarcoma	3.4e-06	9.01e-05	CbGpPWpGaD
Aripiprazole—CHRM3—Signaling Pathways—KRAS—sarcoma	3.39e-06	8.98e-05	CbGpPWpGaD
Aripiprazole—ADRA2A—Signaling Pathways—MYC—sarcoma	3.36e-06	8.92e-05	CbGpPWpGaD
Aripiprazole—HTR1A—Signaling Pathways—HRAS—sarcoma	3.36e-06	8.91e-05	CbGpPWpGaD
Aripiprazole—CHRM2—Signaling Pathways—KRAS—sarcoma	3.35e-06	8.89e-05	CbGpPWpGaD
Aripiprazole—ADRA1B—Signaling Pathways—TP53—sarcoma	3.35e-06	8.87e-05	CbGpPWpGaD
Aripiprazole—ADRA1A—Signaling Pathways—KRAS—sarcoma	3.35e-06	8.87e-05	CbGpPWpGaD
Aripiprazole—HTR2C—Signaling Pathways—HRAS—sarcoma	3.34e-06	8.86e-05	CbGpPWpGaD
Aripiprazole—ADRA2A—Signaling Pathways—EGFR—sarcoma	3.29e-06	8.72e-05	CbGpPWpGaD
Aripiprazole—ADRA2C—Signaling Pathways—HRAS—sarcoma	3.25e-06	8.62e-05	CbGpPWpGaD
Aripiprazole—ADRA1B—Signaling Pathways—HRAS—sarcoma	3.2e-06	8.48e-05	CbGpPWpGaD
Aripiprazole—ADRA2A—Signaling Pathways—KRAS—sarcoma	3.11e-06	8.24e-05	CbGpPWpGaD
Aripiprazole—DRD2—Signaling Pathways—TP53—sarcoma	3.09e-06	8.18e-05	CbGpPWpGaD
Aripiprazole—HTR2A—Signaling Pathways—TP53—sarcoma	3.04e-06	8.05e-05	CbGpPWpGaD
Aripiprazole—HRH1—Signaling Pathways—TP53—sarcoma	3.03e-06	8.03e-05	CbGpPWpGaD
Aripiprazole—CHRM1—Signaling Pathways—TP53—sarcoma	3.02e-06	8.01e-05	CbGpPWpGaD
Aripiprazole—CHRM3—Signaling Pathways—TP53—sarcoma	3.01e-06	7.98e-05	CbGpPWpGaD
Aripiprazole—CHRM2—Signaling Pathways—TP53—sarcoma	2.98e-06	7.9e-05	CbGpPWpGaD
Aripiprazole—ADRA1A—Signaling Pathways—TP53—sarcoma	2.97e-06	7.88e-05	CbGpPWpGaD
Aripiprazole—DRD2—Signaling Pathways—HRAS—sarcoma	2.95e-06	7.82e-05	CbGpPWpGaD
Aripiprazole—HTR2A—Signaling Pathways—HRAS—sarcoma	2.9e-06	7.7e-05	CbGpPWpGaD
Aripiprazole—HRH1—Signaling Pathways—HRAS—sarcoma	2.9e-06	7.68e-05	CbGpPWpGaD
Aripiprazole—CHRM1—Signaling Pathways—HRAS—sarcoma	2.89e-06	7.66e-05	CbGpPWpGaD
Aripiprazole—CHRM3—Signaling Pathways—HRAS—sarcoma	2.88e-06	7.63e-05	CbGpPWpGaD
Aripiprazole—CHRM2—Signaling Pathways—HRAS—sarcoma	2.85e-06	7.56e-05	CbGpPWpGaD
Aripiprazole—ADRA1A—Signaling Pathways—HRAS—sarcoma	2.84e-06	7.54e-05	CbGpPWpGaD
Aripiprazole—ADRA2A—Signaling Pathways—TP53—sarcoma	2.76e-06	7.32e-05	CbGpPWpGaD
Aripiprazole—ADRA2A—Signaling Pathways—HRAS—sarcoma	2.64e-06	7e-05	CbGpPWpGaD
